FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1693489636> ?p ?o ?g. }

• W1693489636 endingPage "23" @default.
• W1693489636 startingPage "1017" @default.
• W1693489636 abstract "Several efforts have been made to find biomarkers that could help clinicians to preoperatively determine prostate cancer (PCa) pathological characteristics and choose the best therapeutic approach, avoiding over-treatment. On this effort, prostate cancer antigen 3 (PCA3), prostate health index (phi) and sarcosine have been presented as promising tools. We evaluated the ability of these biomarkers to predict the pathologic PCa characteristics within a prospectively collected contemporary cohort of patients who underwent radical prostatectomy (RP) for clinically localized PCa at a single high-volume Institution.The prognostic performance of PCA3, phi and sarcosine were evaluated in 78 patients undergoing RP for biopsy-proven PCa. Receiver operating characteristic (ROC) curve analyses tested the accuracy (area under the curve (AUC)) in predicting PCa pathological characteristics. Decision curve analyses (DCA) were used to assess the clinical benefit of the three biomarkers.We found that PCA3, phi and sarcosine levels were significantly higher in patients with tumor volume (TV)≥0.5 ml, pathologic Gleason sum (GS)≥7 and pT3 disease (all p-values≤0.01). ROC curve analysis showed that phi is an accurate predictor of high-stage (AUC 0.85 [0.77-0.93]), high-grade (AUC 0.83 [0.73-0.93]) and high-volume disease (AUC 0.94 [0.88-0.99]). Sarcosine showed a comparable AUC (0.85 [0.76-0.94]) only for T3 stage prediction, whereas PCA3 score showed lower AUCs, ranging from 0.74 (for GS) to 0.86 (for TV).PCA3, phi and sarcosine are predictors of PCa characteristics at final pathology. Successful clinical translation of these findings would reduce the frequency of surveillance biopsies and may enhance acceptance of active surveillance (AS)." @default.
• W1693489636 created "2016-06-24" @default.
• W1693489636 creator A5003929233 @default.
• W1693489636 creator A5006158976 @default.
• W1693489636 creator A5014614796 @default.
• W1693489636 creator A5024107257 @default.
• W1693489636 creator A5024587083 @default.
• W1693489636 creator A5027115920 @default.
• W1693489636 creator A5027197519 @default.
• W1693489636 creator A5028099479 @default.
• W1693489636 creator A5047052351 @default.
• W1693489636 creator A5054031281 @default.
• W1693489636 creator A5060102969 @default.
• W1693489636 creator A5061715144 @default.
• W1693489636 creator A5075294017 @default.
• W1693489636 date "2015-02-01" @default.
• W1693489636 modified "2023-10-08" @default.
• W1693489636 title "Improving the prediction of pathologic outcomes in patients undergoing radical prostatectomy: the value of prostate cancer antigen 3 (PCA3), prostate health index (phi) and sarcosine." @default.
• W1693489636 cites W1550022481 @default.
• W1693489636 cites W1667881669 @default.
• W1693489636 cites W1987998253 @default.
• W1693489636 cites W2016016515 @default.
• W1693489636 cites W2017264713 @default.
• W1693489636 cites W2020293070 @default.
• W1693489636 cites W2032359663 @default.
• W1693489636 cites W2041317081 @default.
• W1693489636 cites W2045030989 @default.
• W1693489636 cites W2051607664 @default.
• W1693489636 cites W2072056153 @default.
• W1693489636 cites W2073372361 @default.
• W1693489636 cites W2081688362 @default.
• W1693489636 cites W2097876373 @default.
• W1693489636 cites W2103764347 @default.
• W1693489636 cites W2107190872 @default.
• W1693489636 cites W2120988323 @default.
• W1693489636 cites W2126179037 @default.
• W1693489636 cites W2142912172 @default.
• W1693489636 cites W2148934838 @default.
• W1693489636 cites W2155680682 @default.
• W1693489636 cites W2166196020 @default.
• W1693489636 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25667489" @default.
• W1693489636 hasPublicationYear "2015" @default.
• W1693489636 type Work @default.
• W1693489636 sameAs 1693489636 @default.
• W1693489636 citedByCount "19" @default.
• W1693489636 countsByYear W16934896362015 @default.
• W1693489636 countsByYear W16934896362016 @default.
• W1693489636 countsByYear W16934896362017 @default.
• W1693489636 countsByYear W16934896362018 @default.
• W1693489636 countsByYear W16934896362019 @default.
• W1693489636 countsByYear W16934896362020 @default.
• W1693489636 countsByYear W16934896362021 @default.
• W1693489636 countsByYear W16934896362022 @default.
• W1693489636 countsByYear W16934896362023 @default.
• W1693489636 crossrefType "journal-article" @default.
• W1693489636 hasAuthorship W1693489636A5003929233 @default.
• W1693489636 hasAuthorship W1693489636A5006158976 @default.
• W1693489636 hasAuthorship W1693489636A5014614796 @default.
• W1693489636 hasAuthorship W1693489636A5024107257 @default.
• W1693489636 hasAuthorship W1693489636A5024587083 @default.
• W1693489636 hasAuthorship W1693489636A5027115920 @default.
• W1693489636 hasAuthorship W1693489636A5027197519 @default.
• W1693489636 hasAuthorship W1693489636A5028099479 @default.
• W1693489636 hasAuthorship W1693489636A5047052351 @default.
• W1693489636 hasAuthorship W1693489636A5054031281 @default.
• W1693489636 hasAuthorship W1693489636A5060102969 @default.
• W1693489636 hasAuthorship W1693489636A5061715144 @default.
• W1693489636 hasAuthorship W1693489636A5075294017 @default.
• W1693489636 hasConcept C121608353 @default.
• W1693489636 hasConcept C126322002 @default.
• W1693489636 hasConcept C126894567 @default.
• W1693489636 hasConcept C143998085 @default.
• W1693489636 hasConcept C146357865 @default.
• W1693489636 hasConcept C151730666 @default.
• W1693489636 hasConcept C185592680 @default.
• W1693489636 hasConcept C207886595 @default.
• W1693489636 hasConcept C2776235491 @default.
• W1693489636 hasConcept C2777756961 @default.
• W1693489636 hasConcept C2779466945 @default.
• W1693489636 hasConcept C2779943223 @default.
• W1693489636 hasConcept C2780192828 @default.
• W1693489636 hasConcept C2781406297 @default.
• W1693489636 hasConcept C515207424 @default.
• W1693489636 hasConcept C55493867 @default.
• W1693489636 hasConcept C58471807 @default.
• W1693489636 hasConcept C71924100 @default.
• W1693489636 hasConcept C76318530 @default.
• W1693489636 hasConcept C86803240 @default.
• W1693489636 hasConcept C87874733 @default.
• W1693489636 hasConceptScore W1693489636C121608353 @default.
• W1693489636 hasConceptScore W1693489636C126322002 @default.
• W1693489636 hasConceptScore W1693489636C126894567 @default.
• W1693489636 hasConceptScore W1693489636C143998085 @default.
• W1693489636 hasConceptScore W1693489636C146357865 @default.
• W1693489636 hasConceptScore W1693489636C151730666 @default.
• W1693489636 hasConceptScore W1693489636C185592680 @default.
• W1693489636 hasConceptScore W1693489636C207886595 @default.
• W1693489636 hasConceptScore W1693489636C2776235491 @default.

• next